Bill Myers

Private credit’s economic troubles are causing political problems for the industry as regulators rethink some of their 'light touch' promises.

Fund managers must show they can deliver good health outcomes if they’re going to stop the spread of antitrust and corporate-practice-of-medicine ideas.

The states prove to be a battlefield for private equity’s future in healthcare, as antitrust and corporate-practice-of-medicine bills spread.

The Madison Capital Funding case reads like a warning to an industry, Weil, Gotshal & Manges poaches David Greene as it builds out its fund formation practice and securities class action lawsuits dip slightly.

Regulators use Trump’s 'America First' order to make it easier for (friendly) foreigners to invest here, private funds are ‘gatekeepers, not bystanders’ in sanctions enforcement, litigation finance has permeated (and warped) the legal profession and Paul Weiss hires a new partner.

Jonathan Epstein has spent more than a decade pushing, pulling and pleading to allow retirement savers to invest in private funds. On the eve of a world-shaking rulemaking notice, he shares his thoughts on how we got here, and where we go next.

The SEC’s staff purge only looks like relief.

AI ‘can, should, and will catalyze a transformation of the technology of investment management,’ Brian Daly says, and regulators want industry’s input on where to put the guardrails.

With Washington’s pressure on the industry eased, fund managers at the 23rd annual Private Funds CFO New York Forum could reset their shoulders, get back to work.

‘It’s unbelievable how well the industry performed for many years,’ Steve Kaplan tells a standing-room-only crowd at Private Funds CFO’s New York Forum.